HispanicBusiness

TORONTO, ONTARIO -- (Marketwired) -- 04/24/13 -- Biologix Hair Inc. (OTCBB: BLGX) (OTCQB: BLGX) is pleased to announce the appointment of Arthur G. Handal M.D., F.A.C.S. to the Company's Medical Advisory Board.

Certified by the American Board of Plastic Surgery, Dr. Arthur G. Handal's interest in plastic/cosmetic surgery began at the Chicago/UHS Medical School and became focused during his residency at State University New York. Handal gained early acceptance into the SUNY/Kings County Medical Center and upon completion of his residency, he continued surgical training with prestigious fellowships in aesthetic surgery in association with the University of Miami and hand surgery at Hartford Hospital in Connecticut. For more than 20 years, Dr. Handal has dedicated his practice to aesthetic plastic surgery.

Dr. Handal's private, professional Sanctuary Surgical Center, affiliated with the Boca Raton Community Hospital offers surgery and pre- and post-operative care in a state of the art, fully licensed facility accredited at the highest level as an ambulatory surgical center, and offers a full range of aesthetic services.

He is a member of the American Society of Plastic Surgeons, American Society for Aesthetic Plastic Surgery, American College of Surgeons, Southeastern Society of Plastic and Reconstructive Surgeons, Palm Beach County Society of Plastic and Reconstructive Surgery Florida Medical Association, Palm Beach County Medical Society and the American Society of Laser Medicine and Surgery. Dr. Handal offers cutting-edge techniques and innovations to his patients, developed through attending the major professional meetings several times a year.

Dr. Arthur Handal commented, "I am pleased to become part of the Biologix Hair Inc. team by serving on its Medical Advisory Board. The ongoing R&D efforts being undertaken by Biologix with the Beijing Institute of Technology and level of professionalism with which the Company is working toward application for regulatory agency approval is a smart strategy. I am particularly impressed with the attention being paid to developing an international distribution channel of licensed clinicians and medical practitioners in advance of FDA approval thereby readying Biologix to penetrate the global market potential for its Biologix Hair Therapy System™."

Ron Holland, Biologix Hair Inc. CEO and Director, welcomed Dr. Handal, commenting: "Dr. Handal's experience and knowledge are of vast benefit to Biologix and we are grateful he's consented to serve on the Biologix Medical Advisory Board. As we further build out the global network of clinicians who wish to become Certified Biologix Hair Therapists™ as well as maintain our ongoing R&D efforts, the advice offered by members of our Medical Advisory Board will be integral to our continuing development. We welcome Dr. Handal to the Biologix team."

About Biologix Hair Inc. and Biologix Hair Science Ltd.

Biologix Hair Inc. (Biologix Hair), together with its wholly owned biotechnology subsidiary, Biologix Hair Science Ltd. ™ (BHS), is focused on realizing the full market potential for its patent-pending hair loss prevention and regeneration treatment - the Biologix Hair Therapy System™ - and its demonstrated ability to prevent and reverse the effects of alopecia, which plagues hundreds of millions worldwide.